Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ARS PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 464,681 shares of SPRY (ARS PHARMACEUTICALS INC), worth $3.7M as of 2026-Q1. The position was increased (+52.6% shares). SPRY represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3.7M
Current Shares
464,681
Total Value Change
+$3.5M
Total Shares Change
+437,600
Other major holders of SPRY: RA CAPITAL MANAGEMENT, L.P.
Increased |
| 464,681 |
+52.6% |
| $3.7M |
| 0.0% |
| $8.87 |
37 |
| 2025-Q4 | Decreased | 304,445 | -9.2% | $3.5M | 0.0% | $11.64 | 0 |
| 2025-Q3 | Increased | 335,148 | +2.9% | $3.4M | 0.0% | $9.72 | 27 |
| 2025-Q2 | Increased | 325,645 | +16.4% | $5.7M | 0.0% | $18.20 | 31 |
| 2025-Q1 | Increased | 279,840 | +13.2% | $3.5M | 0.0% | $12.49 | 30 |
| 2024-Q4 | Increased | 247,314 | +5.5% | $2.6M | 0.0% | $10.62 | 28 |
| 2024-Q3 | Increased | 234,537 | +766.1% | $3.4M | 0.0% | $14.32 | 43 |
| 2024-Q2 | Increased | 27,081 | +109.3% | $230,459 | 0.0% | $8.51 | 37 |